Welcome to our dedicated page for ASTRONICS SEC filings (Ticker: ATRO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ASTRONICS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ASTRONICS's regulatory disclosures and financial reporting.
PEABODY MARK reported acquisition or exercise transactions in this Form 4 filing.
Astronics Corp Executive VP & President of Aerospace Mark Peabody reported an award of 7,675 restricted stock units on February 19, 2026. Each unit represents the right to receive one share of common stock. Vesting depends on Astronics’ average annual adjusted EBITDA for 2026–2028, with 50% to 150% of the target units potentially vesting on February 19, 2029 based on actual performance.
Astronics Corp reported that Principal Accounting Officer Nancy L. Hedges acquired 12,150 restricted stock units on February 19, 2026 as a grant or award. Each unit represents one share of common stock at settlement. The award is performance-based, with vesting tied to Astronics’ average annual adjusted EBITDA for the period from January 1, 2026 to December 31, 2028. Between 50% and 150% of the target number of units may vest on February 19, 2029, depending on actual performance.
West Fay reported acquisition or exercise transactions in this Form 4 filing.
Astronics Corporation director Fay West received a stock bonus award of 1,533 shares of $.01 par value common stock as compensation for service as a director. The shares were awarded on February 19, 2026 at no stated purchase price, increasing West’s directly owned holdings to 7,588 shares.
FRISBY JEFFRY D reported acquisition or exercise transactions in this Form 4 filing.
Astronics Corp director Jeffry D. Frisby received a stock bonus award of 1,533 common shares on February 19, 2026 as compensation for his board service. After this grant, he directly owns 47,056 Astronics common shares, reflecting equity-based compensation rather than an open-market share purchase.
MORAN MARK J reported acquisition or exercise transactions in this Form 4 filing.
Astronics Corporation director Mark J. Moran received a stock bonus award of 1,533 shares of $.01 par value common stock as compensation for his board service. The award was granted at no cash cost and increases his directly owned stake to 44,056 shares.
Mulato James reported acquisition or exercise transactions in this Form 4 filing.
Astronics Corp reported that James Mulato, President of Astronics Test Systems, received a grant of 7,675 restricted stock units on February 19, 2026 at no cash cost. Each unit represents the right to receive one share of common stock at settlement.
The filing explains that vesting of these restricted stock units depends on Astronics Corp's average annual adjusted EBITDA over specified multi‑year periods. Between 50% and 150% of the applicable target unit amounts may vest on future February dates, with the actual vesting percentage determined by the company’s performance.
Capital International Investors has filed a Schedule 13G reporting a passive ownership stake in Astronics Corp. common stock. The firm is deemed to beneficially own 1,849,886 shares, representing 5.9% of Astronics’ 31,619,410 shares believed to be outstanding as of the reported date.
The filing states Capital International Investors has sole voting and dispositive power over all 1,849,886 shares and no shared power. It also certifies the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Astronics.
American Century Investment Management and related entities reported a significant ownership position in Astronics Corporation. They disclosed beneficial ownership of 1,764,235 shares of Astronics common stock, representing 5.6% of the outstanding class as of December 31, 2025.
American Century and its parent American Century Companies, Inc., together with the Stowers Institute for Medical Research, reported sole voting power over 1,453,455 shares and sole dispositive power over 1,764,235 shares, with no shared voting or dispositive power. They certified that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Astronics.
PEABODY MARK reported disposition transactions in a Form 4 filing for ATRO. The filing lists transactions totaling 2,500 shares. Following the reported transactions, holdings were 183,445 shares.
State Street Corporation has disclosed a significant ownership position in Astronics Corp common stock. It reports beneficial ownership of 1,832,179 shares, representing 5.8% of Astronics’ common stock as of 12/31/2025.
State Street has shared voting power over 1,755,956 shares and shared dispositive power over 1,832,179 shares, with no sole voting or dispositive power. The firm states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Astronics.